Загрузка...
PS2-29: KRAS Testing in Metastatic Colorectal Cancer: The CERGEN-C Comparative Effectiveness Study
Genetic testing to inform health professionals and patients of disease risk, diagnostic, prognostic, or treatment information such as KRAS mutation testing to determine colorectal cancer (CRC) treatment is an evolving health care approach. KRAS, a pharmacogenomic marker normally expressed in wild ty...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Marshfield Clinic
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3251389/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2011.1020.ps2-29 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|